Effects of Immunosuppressants on Platelet-Derived Growth Factor-A Chain mRNA Expression and Coronary Arteriosclerosis in Rat Cardiac Allografts

Circulation Journal

Volumn 63, Issue 4, 1999, Pages 303-308

  Hachida, Mitsuhiro ^a   Zhang, Xi Long ^a   Lu, Hua ^a   Hoshi, Hironobu ^a   Koyanagi, Hitoshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary arteriosclerosis; Heart transplantation; Immunosuppressant; Platelet derived growth factor

Indexed keywords

15 DEOXYSPERGUALIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PLATELET DERIVED GROWTH FACTOR A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION FUNCTION; DRUG EFFECT; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; CORONARY ARTERIOSCLEROSIS; CYCLOSPORINE; DRUGS, CHINESE HERBAL; GRAFT REJECTION; GUANIDINES; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; MALE; MYOCARDIUM; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS; TRIPTERYGIUM;

EID: 0032918769     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.303     Document Type: Article

References (30)

1. Uretsky BF, Murali S, Reddy PS et al: Development of coronary disease in cardiac transplant recipients receiving immunosuppressive therapy with cyclosporine A and prednisone. Circulation 1987; 76: 827-834
2. Haverich A, Costard-Jackle A, Cremer J et al: Cyclosporine A and transplant coronary disease after heart transplantation: Facts and Fiction. Transplant Proc 1994; 26: 2713-2715
3. Paul LC, Davidoff A, Benediktsson H: Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor. Transplantation 1994; 57: 1767-1772
4. Zhao XM, Yeoh TK, Frist WH, Porterfield DL, Miller GG: Induction of acidic fibroblast growth factor and full-length platelet-derived growth factor expression in human cardiac allografts. Circulation 1994; 90: 677-685
5. Shaddy RE, Hammond EH, Yowell RL: Immunohistochemical analysis of platelet-derived growth factor and basic fibroblast growth factor in cardiac biopsy and autopsy specimens of heart transplant patients. Am J Cardiol 1996; 77: 1210-1215
6. Barren TB, Benditt EP: Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA 1988; 85: 2810-2814
7. Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D: Platelet-derived growth factor mRNA detection in human atherosclerosis plaques by in situ hybridization. J Clin Invest 1988; 82: 1134-1143
8. Lemstrom KB, Koskinen PK: Expression and localization of platelet-derived growth factor ligand and receptor protein during acute and chronic rejection of rat cardiac allografts. Circulation 1997; 96: 1240-1249
9. Ono K, Lindsey ES: Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225-229
10. Lurie KG, Billingham ME, Jamieson SW, Harrison DC, Reitz BA: Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplantation model. Transplantation 1981; 31: 41-47
11. Nagamine S, Ohmi M, Tabayashi K, Iguchi A, Mohri H: Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in rat. J Heart Lung Transplant 1994; 13: 895-898
12. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491
13. Oana S, Matsuoka R, Nakajima H, Hiratsuka E, Furutani Y, Takao A, et al: Molecular characterization of a novel atrial-specific myosin heavy-chain gene expressed in the chick embryo. Eur J Cell Biol 1995; 61: 42-49
14. Wahlers T, Mugge A, Oppelt P, Heublein B, Fieguth HG, Jurmann MJ, et al: Preventive treatment of coronary vasculopathy in heart transplantation by inhibition of small muscle cell proliferation with angiopeptin. J Heart Lung Transplant 1995; 14: 143-150
15. Li XW, Weir M: Radix tripterygium wilfordii - a chinese herbal medicine with potent immunosuppressive properties. Transplantation 1990; 50: 82
16. Hachida M, Zhang XL, Lu H, Hoshi H, Koyanagi H: Inhibitory effect of Multiglycosidorum tripterygium on coronary arteriosclerosis after heart transplantation. Transplantation 1998; 65: 1446-1450
17. Zhang XL, Hachida M, Lu H, Furukawa H, Hoshi H, Koyanagi H: Effect of 15-deoxyspergualin on coronary arteriosclerosis and platelet-derived growth factor-A mRNA expression in the transplanted heart. J Tokyo Wom Med Coll 1998; 68: 66-72
18. Kronke M, Leonard WJ, Depper JM, et al: Cyclosporine inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 1984; 80: 5214-5218
19. Palay DA, Cluff CW, Wentworth PA, et al: Cyclosporine inhibits macrophage-mediated antigen presentation. J Immunol 1986; 136: 4348-4353
20. Snyder DS, Wright CL, Ting C: Inhibition of human monocyte antigen presentation, but not HLA-DR expression by cyclosporine. Transplantation 1987; 44: 407-411
21. Fujii H, Takada T, Nemoto K, et al: Deoxyspergualin directly suppresses antibody formation in vivo and in vitro. J Antibiot 1990; 43: 213-219
22. Dickneite G, Schorlemmer HU, Sedlacek HH, et al: Suppression of macrophage function and prolongation of graft survival by the new guanidinic-like structure, 15-deoxyspergualin. Transplant Proc 1987; 19: 1301-1304
23. Higgy NA, Davidoff AW, Grothman GT, Hollenberg M, Benediktsson H, Paul LC: Expression of platelet-derived growth factor receptor in rat heart allografts. J Heart Lung Transplant 1991; 10: 1012-1022
24. Vuillemin T, Legendre C, Meduri G, Larue JR, Goupy C, Kriaa F, et al: Chronic rejection and cell growth factor. Transplant Proc 1996; 28: 2831-2832
25. Saito S, Motomura N, Lou H, Ramwell P, Foegh M: Specific Effect of estrogen on growth factor and major histocompatibility complex class II antigen expression in rat aortic allograft. J Thorac Cardiovasc Surg 1997; 114: 803-810
26. Meiser BM, Wenke J, Thiery SW, Wolf S, Devens C, Seidel D, et al: Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model. Transplant Proc 1993; 25: 2077-2079
27. Ventura HO, Mehra MR, Smart RV, Stapleton DD: Cardiac allograft vasculopathy: current concepts. Am Heart J 1995; 129: 791-799
28. Lemstrom K, Koskinen P, Bruning H, Bruggeman C, Aho P, Hayry P: Cytomegalovirus infection accelerates mRNA expression of several smooth muscle cell growth factors in the allograft vascular wall. Transplant Proc 1995; 27: 566-567
29. Hatanaga M, Omoto R: The promoting effect of cytomegalovirus on coronary arteriosclerosis of transplanted hearts. Transplantation 1993; 28: 286-288
30. Lou H, Kodama T, Zhao YJ, Maurice P, Wang YN, Katz N, et al: Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression. Circulation 1996; 94: 3355-3361